150 related articles for article (PubMed ID: 9576012)
1. A newly discovered function for C1 inhibitor, removal of the entire C1qr2s2 complex from immobilized human IgG subclasses.
Chen CH; Boackle RJ
Clin Immunol Immunopathol; 1998 Apr; 87(1):68-74. PubMed ID: 9576012
[TBL] [Abstract][Full Text] [Related]
2. C1 inhibitor removes the entire C1qr2s2 complex from anti-C1Q monoclonal antibodies with low binding affinities.
Chen CH; Lam CF; Boackle RJ
Immunology; 1998 Dec; 95(4):648-54. PubMed ID: 9893058
[TBL] [Abstract][Full Text] [Related]
3. C1q binding to surface-bound IgG is stabilized by C1r
Zwarthoff SA; Widmer K; Kuipers A; Strasser J; Ruyken M; Aerts PC; de Haas CJC; Ugurlar D; den Boer MA; Vidarsson G; van Strijp JAG; Gros P; Parren PWHI; van Kessel KPM; Preiner J; Beurskens FJ; Schuurman J; Ricklin D; Rooijakkers SHM
Proc Natl Acad Sci U S A; 2021 Jun; 118(26):. PubMed ID: 34155115
[TBL] [Abstract][Full Text] [Related]
4. Surfactant protein A regulates complement activation.
Watford WT; Wright JR; Hester CG; Jiang H; Frank MM
J Immunol; 2001 Dec; 167(11):6593-600. PubMed ID: 11714829
[TBL] [Abstract][Full Text] [Related]
5. Autoantibodies against Complement Classical Pathway Components C1q, C1r, C1s and C1-Inh in Patients with Lupus Nephritis.
Radanova M; Vasilev V; Mihaylova G; Kosturkova M; Kishore U; Roumenina L
Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012546
[TBL] [Abstract][Full Text] [Related]
6. Recombinant human complement subcomponent C1s lacking beta-hydroxyasparagine, sialic acid, and one of its two carbohydrate chains still reassembles with C1q and C1r to form a functional C1 complex.
Luo C; Thielens NM; Gagnon J; Gal P; Sarvari M; Tseng Y; Tosi M; Zavodszky P; Arlaud GJ; Schumaker VN
Biochemistry; 1992 May; 31(17):4254-62. PubMed ID: 1533159
[TBL] [Abstract][Full Text] [Related]
7. Antibody-independent activation of C1. II. Evidence for two classes of nonimmune activators of the classical pathway of complement.
Peitsch MC; Kovacsovics TJ; Tschopp J; Isliker H
J Immunol; 1987 Mar; 138(6):1871-6. PubMed ID: 3029223
[TBL] [Abstract][Full Text] [Related]
8. Identification of the C1q-binding Sites of Human C1r and C1s: a refined three-dimensional model of the C1 complex of complement.
Bally I; Rossi V; Lunardi T; Thielens NM; Gaboriaud C; Arlaud GJ
J Biol Chem; 2009 Jul; 284(29):19340-8. PubMed ID: 19473974
[TBL] [Abstract][Full Text] [Related]
9. Cytokines associated with amyloid plaques in Alzheimer's disease brain stimulate human glial and neuronal cell cultures to secrete early complement proteins, but not C1-inhibitor.
Veerhuis R; Janssen I; De Groot CJ; Van Muiswinkel FL; Hack CE; Eikelenboom P
Exp Neurol; 1999 Nov; 160(1):289-99. PubMed ID: 10630213
[TBL] [Abstract][Full Text] [Related]
10. Prospective analysis of C1 dissociation and complement activation in patients with systemic lupus erythematosus.
Jonsson H; Sturfelt G; Mårtensson U; Truedsson L; Sjöholm AG
Clin Exp Rheumatol; 1995; 13(5):573-80. PubMed ID: 8575134
[TBL] [Abstract][Full Text] [Related]
11. Activation of human complement serine-proteinase C1r is down-regulated by a Ca(2+)-dependent intramolecular control that is released in the C1 complex through a signal transmitted by C1q.
Thielens NM; Illy C; Bally IM; Arlaud GJ
Biochem J; 1994 Jul; 301 ( Pt 2)(Pt 2):509-16. PubMed ID: 8042996
[TBL] [Abstract][Full Text] [Related]
12. High molecular weight non-immunoglobulin salivary agglutinins (NIA) bind C1Q globular heads and have the potential to activate the first complement component.
Boackle RJ; Connor MH; Vesely J
Mol Immunol; 1993 Feb; 30(3):309-19. PubMed ID: 8433709
[TBL] [Abstract][Full Text] [Related]
13. Expression of recombinant human complement C1q allows identification of the C1r/C1s-binding sites.
Bally I; Ancelet S; Moriscot C; Gonnet F; Mantovani A; Daniel R; Schoehn G; Arlaud GJ; Thielens NM
Proc Natl Acad Sci U S A; 2013 May; 110(21):8650-5. PubMed ID: 23650384
[TBL] [Abstract][Full Text] [Related]
14. C1 subcomponent complexes: basic and clinical aspects.
Laurell AB; Sjöholm AG
Behring Inst Mitt; 1993 Dec; (93):292-8. PubMed ID: 8172579
[TBL] [Abstract][Full Text] [Related]
15. Secreted chondroitin sulfate proteoglycan of human B cell lines binds to the complement protein C1q and inhibits complex formation of C1.
Kirschfink M; Blase L; Engelmann S; Schwartz-Albiez R
J Immunol; 1997 Feb; 158(3):1324-31. PubMed ID: 9013976
[TBL] [Abstract][Full Text] [Related]
16. Interaction of C1q and mannan-binding lectin (MBL) with C1r, C1s, MBL-associated serine proteases 1 and 2, and the MBL-associated protein MAp19.
Thiel S; Petersen SV; Vorup-Jensen T; Matsushita M; Fujita T; Stover CM; Schwaeble WJ; Jensenius JC
J Immunol; 2000 Jul; 165(2):878-87. PubMed ID: 10878362
[TBL] [Abstract][Full Text] [Related]
17. Activation of the first component of human complement, C1, by monoclonal antibodies directed against different domains of subcomponent C1q.
Kilchherr E; Schumaker VN; Phillips ML; Curtiss LK
J Immunol; 1986 Jul; 137(1):255-62. PubMed ID: 3486914
[TBL] [Abstract][Full Text] [Related]
18. Unique C1 inhibitor dysfunction in a kindred without angioedema. I. A mutant C1 INH that inhibits C1-s but not C1-r.
Wisnieski JJ; Knauss TC; Yike I; Dearborn DG; Narvy RL; Naff GB
J Immunol; 1994 Mar; 152(6):3199-209. PubMed ID: 8144914
[TBL] [Abstract][Full Text] [Related]
19. Complement components C1q, C1r/C1s, and C1INH in rheumatoid arthritis. Correlation of in situ hybridization and northern blot results with function and protein concentration in synovium and primary cell cultures.
Breitner S; Störkel S; Reichel W; Loos M
Arthritis Rheum; 1995 Apr; 38(4):492-8. PubMed ID: 7718002
[TBL] [Abstract][Full Text] [Related]
20. Fluid-phase interaction of C1 inhibitor (C1 Inh) and the subcomponents C1r and C1s of the first component of complement, C1.
Chesne S; Villiers CL; Arlaud GJ; Lacroix MB; Colomb MG
Biochem J; 1982 Jan; 201(1):61-70. PubMed ID: 6282262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
